المؤلفون: King P.

مصطلحات الفهرس: antiinflammatory activity, bronchodilatation, chronic obstructive lung disease/dm [Disease Management], chronic obstructive lung disease/dt [Drug Therapy], clinical trial, drug efficacy, drug fatality/si [Side Effect], drug safety, drug structure, drug tolerability, dry powder, forced expiratory volume, heart depolarization, heart disease/si [Side Effect], heart rate, human, hyperglycemia/si [Side Effect], hypokalemia/si [Side Effect], hypotension/si [Side Effect], lung function, metered dose inhaler, nebulizer, nonhuman, peak expiratory flow, QT prolongation/si [Side Effect], review, side effect/si [Side Effect], tachycardia/si [Side Effect], treatment duration, tremor/si [Side Effect], acetylcysteine/cb [Drug Combination], acetylcysteine/dt [Drug Therapy], arformoterol/ae [Adverse Drug Reaction], arformoterol/ct [Clinical Trial], arformoterol/an [Drug Analysis], arformoterol/cb [Drug Combination], arformoterol/cm [Drug Comparison], arformoterol/do [Drug Dose], arformoterol/dt [Drug Therapy], arformoterol/ih [Inhalational Drug Administration], arformoterol/pd [Pharmacology], formoterol/pd [Pharmacology], ipratropium bromide/cb [Drug Combination], ipratropium bromide/dt [Drug Therapy], long acting drug/dt [Drug Therapy], placebo, salbutamol/cm [Drug Comparison], salbutamol/dt [Drug Therapy], salbutamol/pd [Pharmacology], salmeterol/ae [Adverse Drug Reaction], salmeterol/ct [Clinical Trial], salmeterol/cb [Drug Combination], salmeterol/cm [Drug Comparison], salmeterol/dt [Drug Therapy], drug dose comparison, beta 2 adrenergic receptor stimulating agent/ae [Adverse Drug Reaction], beta 2 adrenergic receptor stimulating agent/cm [Drug Comparison], beta 2 adrenergic receptor stimulating agent/dt [Drug Therapy], beta 2 adrenergic receptor stimulating agent/pd [Pharmacology], budesonide/cb [Drug Combination], budesonide/dt [Drug Therapy], cholinergic receptor blocking agent/cm [Drug Comparison], cholinergic receptor blocking agent/dt [Drug Therapy], cholinergic receptor blocking agent/pd [Pharmacology], formoterol/ct [Clinical Trial], formoterol/an [Drug Analysis], formoterol/cm [Drug Comparison], formoterol/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31724
Click here for full text options
LibKey Link

المؤلفون: King P.

مصطلحات الفهرس: antiinflammatory activity, bronchodilatation, chronic obstructive lung disease/dm [Disease Management], chronic obstructive lung disease/dt [Drug Therapy], clinical trial, drug efficacy, drug fatality/si [Side Effect], drug safety, drug structure, drug tolerability, dry powder, forced expiratory volume, heart depolarization, heart disease/si [Side Effect], heart rate, human, hyperglycemia/si [Side Effect], hypokalemia/si [Side Effect], hypotension/si [Side Effect], lung function, metered dose inhaler, nebulizer, nonhuman, peak expiratory flow, QT prolongation/si [Side Effect], review, side effect/si [Side Effect], tachycardia/si [Side Effect], treatment duration, tremor/si [Side Effect], acetylcysteine/cb [Drug Combination], acetylcysteine/dt [Drug Therapy], arformoterol/ae [Adverse Drug Reaction], arformoterol/ct [Clinical Trial], arformoterol/an [Drug Analysis], arformoterol/cb [Drug Combination], arformoterol/cm [Drug Comparison], arformoterol/do [Drug Dose], arformoterol/dt [Drug Therapy], arformoterol/ih [Inhalational Drug Administration], arformoterol/pd [Pharmacology], formoterol/pd [Pharmacology], ipratropium bromide/cb [Drug Combination], ipratropium bromide/dt [Drug Therapy], long acting drug/dt [Drug Therapy], placebo, salbutamol/cm [Drug Comparison], salbutamol/dt [Drug Therapy], salbutamol/pd [Pharmacology], salmeterol/ae [Adverse Drug Reaction], salmeterol/ct [Clinical Trial], salmeterol/cb [Drug Combination], salmeterol/cm [Drug Comparison], salmeterol/dt [Drug Therapy], drug dose comparison, beta 2 adrenergic receptor stimulating agent/ae [Adverse Drug Reaction], beta 2 adrenergic receptor stimulating agent/cm [Drug Comparison], beta 2 adrenergic receptor stimulating agent/dt [Drug Therapy], beta 2 adrenergic receptor stimulating agent/pd [Pharmacology], budesonide/cb [Drug Combination], budesonide/dt [Drug Therapy], cholinergic receptor blocking agent/cm [Drug Comparison], cholinergic receptor blocking agent/dt [Drug Therapy], cholinergic receptor blocking agent/pd [Pharmacology], formoterol/ct [Clinical Trial], formoterol/an [Drug Analysis], formoterol/cm [Drug Comparison], formoterol/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31724
LibKey Link